While both the United States and Europe strive to provide excellent cancer care, their approaches differ substantially. The US often emphasizes innovative treatments, sometimes leading to greater costs. In contrast, European systems tend to prioritize proactive care and cost-effectiveness, highlighting early diagnosis. This can result in distinct p